noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Hillary Scholten

Rep. Scholten Statement on Impeachment Procedural Vote
United States Bankruptcy Court for[...]

Genger et al v. Genger - Memorandum Decision and Order signed on[...]
Georgia College & State University

More than 400 bachelor’s, master’s and doctoral grads celebrate[...]

Healthcare

Eisai Inc.

05/27/2025 | Press release | Distributed by Public on 05/28/2025 08:23

New Drug Approval for In-House Developed Anti-Insomnia Drug DAYVIGO® (Lemborexant) in China

This is the website of Eisai Inc., a US company. This site is intended for US residents only. The health information contained
herein is provided for educational purposes only and is not intended to replace discussions with a health care provider. All
decisions regarding patient care must be made with a health care provider, considering the unique characteristics of the patient.

Eisai Inc. published this content on May 27, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 28, 2025 at 14:23 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]

Back

View original format